EFIDAC 24 CHLORPHENIRAMINE MALEATE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Efidac 24 Chlorpheniramine Maleate, and what generic alternatives are available?

Efidac 24 Chlorpheniramine Maleate is a drug marketed by Alza and is included in one NDA.

The generic ingredient in EFIDAC 24 CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Efidac 24 Chlorpheniramine Maleate

A generic version of EFIDAC 24 CHLORPHENIRAMINE MALEATE was approved as chlorpheniramine maleate by AVANTHI INC on May 13^th, 2009.

Try a Trial

Summary for EFIDAC 24 CHLORPHENIRAMINE MALEATE

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	81
Patent Applications:	2,749
Formulation / Manufacturing:	see details
DailyMed Link:	EFIDAC 24 CHLORPHENIRAMINE MALEATE at DailyMed

Drug patent expirations by year for EFIDAC 24 CHLORPHENIRAMINE MALEATE

Anatomical Therapeutic Chemical (ATC) Classes for EFIDAC 24 CHLORPHENIRAMINE MALEATE

D04AA	Antihistamines for topical use
D04A	ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
D04	ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
D	Dermatologicals

R06AB	Substituted alkylamines
R06A	ANTIHISTAMINES FOR SYSTEMIC USE
R06	ANTIHISTAMINES FOR SYSTEMIC USE
R	Respiratory system

US Patents and Regulatory Information for EFIDAC 24 CHLORPHENIRAMINE MALEATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alza	EFIDAC 24 CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate	TABLET, EXTENDED RELEASE;ORAL	019746-002	Nov 18, 1994		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for EFIDAC 24 CHLORPHENIRAMINE MALEATE

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alza	EFIDAC 24 CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate	TABLET, EXTENDED RELEASE;ORAL	019746-002	Nov 18, 1994	⤷ Try a Trial	⤷ Try a Trial
Alza	EFIDAC 24 CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate	TABLET, EXTENDED RELEASE;ORAL	019746-002	Nov 18, 1994	⤷ Try a Trial	⤷ Try a Trial
Alza	EFIDAC 24 CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate	TABLET, EXTENDED RELEASE;ORAL	019746-002	Nov 18, 1994	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for EFIDAC 24 CHLORPHENIRAMINE MALEATE

See the table below for patents covering EFIDAC 24 CHLORPHENIRAMINE MALEATE around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Austria	A150889		⤷ Try a Trial
Australia	2306884		⤷ Try a Trial
Denmark	88884		⤷ Try a Trial
European Patent Office	0247709	CHLORPHENIRAMINE THERAPY	⤷ Try a Trial
Italy	8467204		⤷ Try a Trial
Norway	170667		⤷ Try a Trial
United Kingdom	2135880	OSMOTIC DRUG DELIVERY DEVICE	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for EFIDAC 24 CHLORPHENIRAMINE MALEATE

Anatomical Therapeutic Chemical (ATC) Classes for EFIDAC 24 CHLORPHENIRAMINE MALEATE

Make Better Decisions: Try a trial or see plans & pricing